Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

GE Healthcare Technologies Company

GEHC
US36266G1076
A3D3G6

Price

91.42
Today +/-
+1.40
Today %
+1.70 %
P

GE Healthcare Technologies stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the GE Healthcare Technologies stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the GE Healthcare Technologies stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the GE Healthcare Technologies stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze GE Healthcare Technologies's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

GE Healthcare Technologies Stock Price History

DateGE Healthcare Technologies Price
10/4/202491.42 undefined
10/3/202489.88 undefined
10/2/202491.04 undefined
10/1/202491.67 undefined
9/30/202493.85 undefined
9/27/202491.99 undefined
9/26/202492.49 undefined
9/25/202493.01 undefined
9/24/202492.21 undefined
9/23/202490.88 undefined
9/20/202490.28 undefined
9/19/202490.62 undefined
9/18/202488.53 undefined
9/17/202486.79 undefined
9/16/202486.64 undefined
9/13/202486.91 undefined
9/12/202487.46 undefined
9/11/202487.19 undefined
9/10/202485.55 undefined
9/9/202485.12 undefined

GE Healthcare Technologies Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into GE Healthcare Technologies, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by GE Healthcare Technologies from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects GE Healthcare Technologies’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of GE Healthcare Technologies. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into GE Healthcare Technologies’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing GE Healthcare Technologies’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on GE Healthcare Technologies’s growth potential.

GE Healthcare Technologies Revenue, EBIT and net profit per share

DateGE Healthcare Technologies RevenueGE Healthcare Technologies EBITGE Healthcare Technologies Net Income
2028e26.98 B undefined4.95 B undefined3.38 B undefined
2027e25.1 B undefined4.42 B undefined2.96 B undefined
2026e22.19 B undefined3.82 B undefined2.45 B undefined
2025e21.17 B undefined3.45 B undefined2.21 B undefined
2024e20.15 B undefined3.18 B undefined1.98 B undefined
202319.55 B undefined2.44 B undefined1.39 B undefined
202218.34 B undefined2.52 B undefined1.92 B undefined
202117.59 B undefined2.8 B undefined2.25 B undefined
202017.16 B undefined2.72 B undefined13.85 B undefined
201916.63 B undefined2.12 B undefined1.52 B undefined

GE Healthcare Technologies Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (B)EBIT MARGIN (%)NET INCOME (B)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
201920202021202220232024e2025e2026e2027e2028e
16.6317.1617.5918.3419.5520.1521.1722.1925.126.98
-3.192.454.306.603.055.084.8013.137.49
39.3739.4340.8039.1440.52-----
6.556.777.177.187.9200000
2.122.722.82.522.443.183.453.824.424.95
12.7715.8515.8913.7512.4515.7816.3117.2017.6218.33
1.5213.852.251.921.391.982.212.452.963.38
-808.53-83.77-14.73-27.7142.6711.8910.8120.6914.20
454.71454.71454.71453.9345800000
----------
Details

Keystats

ⓘ

Revenue and Growth

The GE Healthcare Technologies Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the GE Healthcare Technologies is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (B)OTHER REC. (M)INVENTORIES (B)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (B)GOODWILL (B)OTHER NON-CURRENT ASSETS (B)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (B)PROVISIONS (M)OTHER SHORT-TERM LIAB. (B)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (B)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (B)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
2020202120222023
       
1.010.561.452.5
2.714.034.284.53
177321732
1.591.952.161.96
413437417389
5.978.329.41
2.22.242.312.5
0000
135138145124
1.61.851.521.25
11.8712.8912.8112.94
2.522.22.436.23
18.3319.3119.2223.04
24.2326.3127.5432.45
       
0005
0006.49
15.5717.6911.241.33
-839-1,037-1,878-691
0000
14.7316.669.367.13
2.162.542.942.95
128104104110
4.234.114.134.92
0080
00.010.011.01
6.526.767.198.98
0.030.038.238.44
45938537068
2.242.242.157.66
2.732.6510.7616.16
9.259.4117.9525.14
23.9826.0727.332.28
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of GE Healthcare Technologies provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand GE Healthcare Technologies's financial health and stability.

Assets

GE Healthcare Technologies's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that GE Healthcare Technologies must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of GE Healthcare Technologies after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into GE Healthcare Technologies's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20192020202120222023
1.682.062.281.951.62
659630625633610
00000
-409-722-1,893-946-278
-93652676544265
7346210570
08090851474
1.842.621.612.112.1
-331-259-248-310-387
-313-323-1,761-398-558
18-64-1,513-88-171
00000
-0.06-0.02-0.018.21.14
00000
-1,435-2,166-263-822-478
-1,376.00-2,150.00-251.00-9,026.00-1,576.00
0000-41
0.040.14-0.450.891.06
1,5072,3591,3591,8031,714
00000

GE Healthcare Technologies stock margins

The GE Healthcare Technologies margin analysis displays the gross margin, EBIT margin, as well as the profit margin of GE Healthcare Technologies. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for GE Healthcare Technologies.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the GE Healthcare Technologies's sales revenue. A higher gross margin percentage indicates that the GE Healthcare Technologies retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the GE Healthcare Technologies's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the GE Healthcare Technologies's total revenue generated. When comparing the revenue margin year over year, investors can gauge the GE Healthcare Technologies's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the GE Healthcare Technologies. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the GE Healthcare Technologies's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

GE Healthcare Technologies Margin History

GE Healthcare Technologies Gross marginGE Healthcare Technologies Profit marginGE Healthcare Technologies EBIT marginGE Healthcare Technologies Profit margin
2028e40.52 %18.33 %12.52 %
2027e40.52 %17.62 %11.78 %
2026e40.52 %17.2 %11.04 %
2025e40.52 %16.31 %10.44 %
2024e40.52 %15.78 %9.81 %
202340.52 %12.45 %7.08 %
202239.14 %13.75 %10.45 %
202140.8 %15.89 %12.78 %
202039.43 %15.85 %80.67 %
201939.37 %12.77 %9.16 %

GE Healthcare Technologies Stock Sales Revenue, EBIT, Earnings per Share

The GE Healthcare Technologies earnings per share therefore indicates how much revenue GE Healthcare Technologies has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue GE Healthcare Technologies earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates GE Healthcare Technologies's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of GE Healthcare Technologies’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating GE Healthcare Technologies's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

GE Healthcare Technologies Revenue, EBIT and net profit per share

DateGE Healthcare Technologies Sales per ShareGE Healthcare Technologies EBIT per shareGE Healthcare Technologies Earnings per Share
2028e59.09 undefined0 undefined7.4 undefined
2027e54.97 undefined0 undefined6.48 undefined
2026e48.59 undefined0 undefined5.37 undefined
2025e46.36 undefined0 undefined4.84 undefined
2024e44.12 undefined0 undefined4.33 undefined
202342.69 undefined5.32 undefined3.02 undefined
202240.41 undefined5.56 undefined4.22 undefined
202138.67 undefined6.15 undefined4.94 undefined
202037.75 undefined5.98 undefined30.45 undefined
201936.58 undefined4.67 undefined3.35 undefined

GE Healthcare Technologies business model

GE Healthcare Technologies is one of the most popular companies on Eulerpool.com.

GE Healthcare Technologies Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

GE Healthcare Technologies historical P/E ratio, EBIT multiple, and P/S ratio

GE Healthcare Technologies shares outstanding

The number of shares was GE Healthcare Technologies in 2023 — This indicates how many shares 458 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue GE Healthcare Technologies earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates GE Healthcare Technologies's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of GE Healthcare Technologies’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating GE Healthcare Technologies's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

GE Healthcare Technologies dividend history and estimates

In 2023, GE Healthcare Technologies paid a dividend amounting to 0.09 USD. Dividend means that GE Healthcare Technologies distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for GE Healthcare Technologies provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify GE Healthcare Technologies’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating GE Healthcare Technologies's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

GE Healthcare Technologies Dividend History

DateGE Healthcare Technologies Dividend
20230.09 undefined
GE Healthcare Technologies does not pay out any dividends.
Unfortunately, there are currently no price targets and forecasts available for GE Healthcare Technologies.

GE Healthcare Technologies latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20241 1  (0.18 %)2024 Q2
3/31/20240.92 0.9  (-2.68 %)2024 Q1
12/31/20231.09 1.18  (8.08 %)2023 Q4
9/30/20230.91 0.99  (8.23 %)2023 Q3
6/30/20230.89 0.92  (3.67 %)2023 Q2
3/31/20230.81 0.85  (5.15 %)2023 Q1
12/31/20220 1.31  (0 %)2022 Q4
1

Eulerpool ESG Scorecard© for the GE Healthcare Technologies stock

Eulerpool World ESG Rating (EESG©)

51/ 100

🌱 Environment

53

👫 Social

51

🏛️ Governance

48

Environment

Scope 1 - Direct Emissions
118,000
Scope 2 - Indirect emissions from purchased energy
186,000
Scope 3 - Indirect emissions within the value chain
6,800,000
Total CO₂ emissions
304,000
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
❌
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
❌
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
❌

Social

Percentage of female employees32.1
Percentage of women in management—
Percentage of Asian employees10.5
Share of Asian management13.8
Percentage of Hispanic/Latino employees8.3
Hispano/Latino Management share6
Percentage of Black employees7.2
Black Management Share2.1
Percentage of white employees71.4
White Management Share76.4
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept✅
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting✅
Stakeholder Engagement✅
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

GE Healthcare Technologies shareholders

%
Name
Stocks
Change
Date
6.68578 % General Electric Co30,531,302-16,100,0003/31/2024
4.26915 % BlackRock Institutional Trust Company, N.A.19,495,490241,27512/31/2023
4.06954 % State Street Global Advisors (US)18,583,969169,04812/31/2023
3.71818 % Dodge & Cox16,979,428-153,56412/31/2023
2.53243 % T. Rowe Price Associates, Inc.11,564,580-172,67212/31/2023
11.24353 % Capital Research Global Investors51,344,7191,401,56612/31/2023
10.18350 % The Vanguard Group, Inc.46,503,9792,268,0522/29/2024
1.87343 % Invesco Capital Management (QQQ Trust)8,555,184-34,2713/31/2024
1.69346 % Geode Capital Management, L.L.C.7,733,367152,77612/31/2023
1.58955 % T. Rowe Price Investment Management, Inc.7,258,8592,060,64412/31/2023
1
2
3
4
5
...
10

Most common questions regarding GE Healthcare Technologies

What is the P/E ratio of GE Healthcare Technologies 2024?

The GE Healthcare Technologies P/E ratio is 21.18.

What is the P/S ratio of GE Healthcare Technologies 2024?

The GE Healthcare Technologies P/S ratio is 2.08.

What is the Quality Investing of GE Healthcare Technologies?

The Quality Investing for GE Healthcare Technologies is 2/10.

What is the revenue of GE Healthcare Technologies 2024?

The expected GE Healthcare Technologies revenue is 20.15 B USD.

How high is the profit of GE Healthcare Technologies 2024?

The expected GE Healthcare Technologies profit is 1.98 B USD.

What is the business model of GE Healthcare Technologies

No history available for GE Healthcare Technologies.

What is the GE Healthcare Technologies dividend?

GE Healthcare Technologies pays a dividend of 0 USD distributed over payouts per year.

How often does GE Healthcare Technologies pay dividends?

The dividend cannot currently be calculated for GE Healthcare Technologies or the company does not pay out a dividend.

What is the GE Healthcare Technologies ISIN?

The ISIN of GE Healthcare Technologies is US36266G1076.

What is the GE Healthcare Technologies WKN?

The WKN of GE Healthcare Technologies is A3D3G6.

What is the GE Healthcare Technologies ticker?

The ticker of GE Healthcare Technologies is GEHC.

How much dividend does GE Healthcare Technologies pay?

Over the past 12 months, GE Healthcare Technologies paid a dividend of 0.09 USD . This corresponds to a dividend yield of about 0.1 %. For the coming 12 months, GE Healthcare Technologies is expected to pay a dividend of 0.09 USD.

What is the dividend yield of GE Healthcare Technologies?

The current dividend yield of GE Healthcare Technologies is 0.1 %.

When does GE Healthcare Technologies pay dividends?

GE Healthcare Technologies pays a quarterly dividend. This is distributed in the months of February, May, August, November.

How secure is the dividend of GE Healthcare Technologies?

GE Healthcare Technologies paid dividends every year for the past 0 years.

What is the dividend of GE Healthcare Technologies?

For the upcoming 12 months, dividends amounting to 0.09 USD are expected. This corresponds to a dividend yield of 0.1 %.

In which sector is GE Healthcare Technologies located?

GE Healthcare Technologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von GE Healthcare Technologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of GE Healthcare Technologies from 11/15/2024 amounting to 0.03 USD, you needed to have the stock in your portfolio before the ex-date on 10/18/2024.

When did GE Healthcare Technologies pay the last dividend?

The last dividend was paid out on 11/15/2024.

What was the dividend of GE Healthcare Technologies in the year 2023?

In the year 2023, GE Healthcare Technologies distributed 0 USD as dividends.

In which currency does GE Healthcare Technologies pay out the dividend?

The dividends of GE Healthcare Technologies are distributed in USD.

All fundamentals about GE Healthcare Technologies

Our stock analysis for GE Healthcare Technologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of GE Healthcare Technologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.